Cargando…

Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy

Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT) has become a therapeutic option for first-line consolidation in Acute Myeloid Leukemia (AML) patients with favorable and intermediate risk features. A total of 101 AML patients in first complete remission, who were not eligible for allog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yegin, Zeynep Arzu, Dikyar, Asena, Aydın Kaynar, Lale, Can, Ferda, Özkurt, Zübeyde Nur, Yağcı, Münci
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731661/ https://www.ncbi.nlm.nih.gov/pubmed/33324478 http://dx.doi.org/10.4081/hr.2020.8380

Ejemplares similares

The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Yegin, Zeynep Arzu, et al.
Publicado: (2020)

Prevalence of Monoclonal B Lymphocytosis in First-Degree Relatives of Chronic Lymphocytic Leukemia Patients in Turkey
por: Demirci, Taner, et al.
Publicado: (2015)

Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
por: AYGENCEL, Gülbin, et al.
Publicado: (2021)

Risk factors for ICU mortality in patients with hematological malignancies: a single-center, retrospective cohort study from Turkey
por: AYGENCEL, Gülbin, et al.
Publicado: (2022)

The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients
por: Aydın Kaynar, Lale, et al.
Publicado: (2023)

A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies
por: Özkurt, Zübeyde Nur, et al.
Publicado: (2016)

Is It Possible to Predict Pulmonary Complications and Mortality in Hematopoietic Stem Cell Transplantation Recipients from Pre-Transplantation Exhaled Nitric Oxide Levels?
por: Köktürk, Nurdan, et al.
Publicado: (2016)

Factors Associated with Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: Human Leukocyte Antigens Might Be Among the Risk Factors
por: Acar1, Kadir, et al.
Publicado: (2014)

Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
por: Byun, Ja Min, et al.
Publicado: (2021)

Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015)

CORRIGENDUM to “Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?”
Publicado: (2021)

Ibrutinib-associated alveolar hemorrhage and spontaneous hemothorax
por: Tombul, Ismail, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
por: Civriz Bozdağ, Sinem, et al.
Publicado: (2022)

P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA
por: Garcia Gutierrez, Valentin, et al.
Publicado: (2023)

HIGH PROBABILITY OF LONG-TERM SURVIVAL IN 2-YEAR SURVIVORS OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN FIRST OR SECOND COMPLETE REMISSION
por: Majhail, Navneet S., et al.
Publicado: (2010)

Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma
por: Wilke, Christopher, et al.
Publicado: (2017)

Neutrophil/lymphocyte ratio, a possible diagnostic marker in clinical practice
por: Ocal, Nesrin, et al.
Publicado: (2015)

Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission
por: Noguchi, Yusuke, et al.
Publicado: (2018)

Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
por: Vargas, Alberto Olaya, et al.
Publicado: (2013)

Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT
por: Drozd-Sokołowska, Joanna, et al.
Publicado: (2022)

Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission
por: Chen, Juan, et al.
Publicado: (2022)

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis
por: Czyz, Anna, et al.
Publicado: (2013)

Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
por: Kletzel, Morris
Publicado: (2013)

Hodgkin’s lymphoma: post- autologous transplantation consolidation therapy
por: Merli, Francesco, et al.
Publicado: (2020)

P1369: PRETRANSPLANT MODIFIED ENDOTHELIAL ACTIVATION AND STRESS INDEX (M-EASIX-7): A PREDICTOR OF PROGNOSIS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Savaş, E. M., et al.
Publicado: (2022)

The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies
por: Yağcı, Münci, et al.
Publicado: (2015)

Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
por: Güven, Zeynep Tuğba, et al.
Publicado: (2022)

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan
por: Takahashi, Naoto, et al.
Publicado: (2018)

Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations
por: Koschade, Sebastian E., et al.
Publicado: (2022)

Successful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT)
por: Sivgin, Serdar, et al.
Publicado: (2013)

Remission of a long-lasting sarcoidosis after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
por: Ginoux, Emmanuelle, et al.
Publicado: (2016)

CAR‐T therapy as a consolidation in remission B‐ALL patients with poor prognosis
por: Yin, Zhichao, et al.
Publicado: (2022)

Blastic Plasmacytoid Dendritic Cell Leukemia Successfully Treated by Autologous Hematopoietic Stem Cell Transplantation to a Remission of 48-Month Duration
por: Goren Sahin, Deniz, et al.
Publicado: (2013)

Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: A case report
por: Chen, Wencui, et al.
Publicado: (2018)

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission
por: Bueno, Nadjanara Dorna, et al.
Publicado: (2011)

Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis
por: Masetti, Riccardo, et al.
Publicado: (2022)

Bacteremia in Hematopoietic Stem Cell Recipients Receiving Fluoroquinolone Prophylaxis: Incidence, Resistance, and Risk Factors
por: Eryilmaz-Eren, Esma, et al.
Publicado: (2022)

Retrospective Evaluation of Effects of Preoperative Anaemia Treatment in Gynaecological and Obstetric Surgical Patients
por: Günaydın, Berrin, et al.
Publicado: (2021)

Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease
por: Sergijenko, Ana, et al.
Publicado: (2013)

Durable Leukemic Remission and Autologous Marrow Recovery with Random Chromosomal Abnormalities after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
por: Nishikii, Hidekazu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dbh6o119lvv4nap92m98h3flbc